averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MNT
|
ENSG00000070444.10 | MAX network transcriptional repressor |
HEY1
|
ENSG00000164683.12 | hes related family bHLH transcription factor with YRPW motif 1 |
HEY2
|
ENSG00000135547.4 | hes related family bHLH transcription factor with YRPW motif 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HEY2 | hg19_v2_chr6_+_126070726_126070768 | 0.65 | 4.6e-28 | Click! |
HEY1 | hg19_v2_chr8_-_80680078_80680101 | 0.29 | 1.1e-05 | Click! |
MNT | hg19_v2_chr17_-_2304365_2304412 | -0.26 | 9.9e-05 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.5 | 132.6 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
24.1 | 48.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
17.5 | 69.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
15.5 | 124.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
13.9 | 138.5 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
13.3 | 39.9 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
11.7 | 11.7 | GO:0045347 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
10.2 | 30.7 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
10.1 | 30.2 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
9.7 | 29.0 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
9.2 | 27.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
8.6 | 25.7 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
8.3 | 25.0 | GO:0051039 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
8.3 | 16.5 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
8.0 | 8.0 | GO:1900369 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
8.0 | 63.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
7.9 | 23.8 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
7.4 | 14.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
7.3 | 14.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
7.3 | 36.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
7.2 | 28.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
7.2 | 28.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
7.0 | 28.0 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
6.7 | 6.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
6.4 | 19.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
6.1 | 18.3 | GO:1903401 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transmembrane transport(GO:1903401) L-lysine import into cell(GO:1903410) |
6.1 | 18.2 | GO:1902960 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
5.8 | 29.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
5.6 | 101.3 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
5.6 | 16.8 | GO:0021722 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
5.6 | 22.4 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
5.6 | 16.7 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
5.5 | 22.0 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
5.5 | 16.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
5.3 | 144.4 | GO:0006884 | cell volume homeostasis(GO:0006884) |
5.3 | 10.6 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
5.2 | 15.6 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
5.2 | 15.6 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
5.2 | 5.2 | GO:0052803 | histidine metabolic process(GO:0006547) imidazole-containing compound metabolic process(GO:0052803) |
5.1 | 25.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
5.1 | 15.3 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
5.1 | 25.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
5.0 | 15.0 | GO:1990523 | negative regulation of neuromuscular junction development(GO:1904397) bone regeneration(GO:1990523) |
5.0 | 20.0 | GO:1902075 | cellular response to salt(GO:1902075) |
4.9 | 19.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
4.9 | 19.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
4.8 | 24.2 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
4.6 | 9.3 | GO:0003250 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
4.6 | 13.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
4.5 | 75.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
4.3 | 30.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
4.3 | 25.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
4.2 | 16.9 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
4.2 | 25.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
4.2 | 29.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
4.1 | 24.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
4.1 | 4.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
4.0 | 19.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
3.8 | 23.0 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
3.8 | 11.5 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
3.8 | 3.8 | GO:0035106 | operant conditioning(GO:0035106) |
3.8 | 11.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
3.8 | 7.5 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
3.7 | 22.3 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
3.7 | 11.1 | GO:0003285 | septum secundum development(GO:0003285) |
3.6 | 18.1 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) Harderian gland development(GO:0070384) |
3.6 | 39.3 | GO:0015886 | heme transport(GO:0015886) |
3.5 | 10.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
3.5 | 10.6 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
3.5 | 3.5 | GO:0051885 | positive regulation of anagen(GO:0051885) |
3.5 | 24.5 | GO:0019532 | oxalate transport(GO:0019532) |
3.5 | 27.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
3.4 | 10.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
3.4 | 13.7 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
3.4 | 17.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
3.4 | 10.1 | GO:0003175 | tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) negative regulation of transcription by transcription factor localization(GO:0010621) |
3.2 | 9.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
3.2 | 3.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
3.2 | 9.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
3.1 | 9.4 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
3.1 | 15.3 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
3.0 | 9.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
3.0 | 11.9 | GO:0010157 | response to chlorate(GO:0010157) |
2.9 | 20.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.9 | 5.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.9 | 5.7 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
2.8 | 30.8 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
2.7 | 19.1 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
2.7 | 40.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
2.7 | 8.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
2.7 | 24.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
2.7 | 8.0 | GO:0060437 | lung growth(GO:0060437) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
2.6 | 10.4 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
2.5 | 4.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
2.5 | 32.0 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
2.4 | 22.0 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.4 | 14.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.4 | 19.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.4 | 7.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
2.4 | 4.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
2.3 | 7.0 | GO:0035606 | induction of programmed cell death(GO:0012502) peptidyl-cysteine S-trans-nitrosylation(GO:0035606) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
2.3 | 6.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
2.3 | 20.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.2 | 31.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
2.2 | 4.3 | GO:0007412 | axon target recognition(GO:0007412) |
2.1 | 6.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
2.1 | 21.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
2.1 | 8.6 | GO:0009386 | translational attenuation(GO:0009386) |
2.1 | 8.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
2.1 | 23.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
2.1 | 29.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
2.1 | 4.1 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
2.1 | 10.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
2.0 | 8.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.0 | 7.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
2.0 | 5.9 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
1.9 | 13.5 | GO:0050893 | sensory processing(GO:0050893) |
1.9 | 9.6 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.9 | 3.8 | GO:0051026 | chiasma assembly(GO:0051026) |
1.9 | 5.6 | GO:0097359 | UDP-glucosylation(GO:0097359) |
1.9 | 5.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.8 | 3.6 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
1.8 | 32.2 | GO:0007141 | male meiosis I(GO:0007141) |
1.8 | 26.7 | GO:0014029 | neural crest formation(GO:0014029) |
1.8 | 5.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
1.8 | 23.0 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.8 | 7.0 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.7 | 29.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.7 | 10.4 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
1.7 | 6.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
1.7 | 6.8 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
1.7 | 5.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.7 | 5.1 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
1.7 | 10.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.7 | 5.0 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.7 | 8.4 | GO:0071543 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
1.7 | 10.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.6 | 11.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.6 | 4.9 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.6 | 16.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.6 | 8.2 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
1.6 | 11.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.6 | 26.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
1.6 | 8.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.6 | 6.3 | GO:0015808 | L-alanine transport(GO:0015808) |
1.6 | 4.7 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
1.6 | 25.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
1.6 | 9.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.6 | 4.7 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.5 | 15.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
1.5 | 6.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.5 | 6.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.5 | 4.5 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
1.5 | 10.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.5 | 10.5 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.5 | 20.8 | GO:0035878 | nail development(GO:0035878) |
1.5 | 1.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.5 | 11.7 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.4 | 8.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.4 | 47.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.4 | 2.9 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.4 | 5.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.4 | 7.1 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.4 | 9.8 | GO:0045007 | depurination(GO:0045007) |
1.4 | 5.6 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.4 | 37.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.4 | 20.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.3 | 4.0 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
1.3 | 5.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.3 | 6.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
1.3 | 3.9 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) positive regulation of NK T cell differentiation(GO:0051138) germline stem cell asymmetric division(GO:0098728) |
1.3 | 7.7 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
1.3 | 5.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
1.3 | 5.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
1.3 | 1.3 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
1.3 | 6.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.3 | 8.8 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
1.3 | 15.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
1.2 | 2.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
1.2 | 3.7 | GO:0061055 | myotome development(GO:0061055) |
1.2 | 18.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
1.2 | 7.3 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.2 | 12.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.2 | 9.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.2 | 9.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.2 | 3.6 | GO:0007497 | posterior midgut development(GO:0007497) |
1.2 | 2.4 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
1.2 | 21.4 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
1.2 | 9.5 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
1.2 | 8.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.2 | 8.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.2 | 13.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.2 | 1.2 | GO:1902961 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
1.1 | 13.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.1 | 13.7 | GO:0006108 | malate metabolic process(GO:0006108) |
1.1 | 13.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.1 | 6.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.1 | 10.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.1 | 4.5 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
1.1 | 11.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
1.1 | 16.8 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
1.1 | 25.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
1.1 | 2.2 | GO:0006907 | pinocytosis(GO:0006907) |
1.1 | 13.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
1.1 | 6.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.1 | 3.3 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.1 | 10.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
1.1 | 7.5 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.1 | 3.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
1.1 | 2.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
1.1 | 3.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 12.7 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.0 | 5.2 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
1.0 | 9.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.0 | 8.2 | GO:0006531 | aspartate metabolic process(GO:0006531) |
1.0 | 4.1 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
1.0 | 19.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.0 | 3.0 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
1.0 | 3.0 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
1.0 | 2.0 | GO:0031133 | regulation of axon diameter(GO:0031133) |
1.0 | 4.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.0 | 4.9 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
1.0 | 2.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
1.0 | 6.7 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.0 | 1.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.9 | 0.9 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.9 | 67.7 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.9 | 8.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.9 | 9.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.9 | 8.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.9 | 40.6 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.9 | 21.1 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.9 | 2.7 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.9 | 6.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.9 | 8.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.9 | 1.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.8 | 4.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.8 | 3.4 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 7.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.8 | 6.7 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.8 | 1.7 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.8 | 7.4 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.8 | 9.8 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.8 | 3.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.8 | 2.4 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.8 | 8.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.8 | 6.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.8 | 14.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.8 | 29.0 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.8 | 6.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.8 | 12.5 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.8 | 14.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.8 | 2.3 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.8 | 3.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.8 | 1.5 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.8 | 3.8 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.8 | 18.9 | GO:0007628 | adult walking behavior(GO:0007628) |
0.8 | 16.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.7 | 45.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.7 | 8.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.7 | 2.2 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.7 | 4.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.7 | 5.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.7 | 3.0 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.7 | 20.7 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.7 | 0.7 | GO:0060157 | urinary bladder development(GO:0060157) |
0.7 | 3.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.7 | 2.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.7 | 2.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.7 | 2.2 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 15.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.7 | 10.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.7 | 8.6 | GO:0030238 | male sex determination(GO:0030238) |
0.7 | 2.8 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.7 | 2.1 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.7 | 2.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.7 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.7 | 26.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.7 | 2.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.7 | 68.0 | GO:0007286 | spermatid development(GO:0007286) |
0.7 | 8.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 2.0 | GO:0035936 | testosterone secretion(GO:0035936) regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.6 | 1.9 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.6 | 5.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 14.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.6 | 9.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.6 | 4.5 | GO:0060068 | vagina development(GO:0060068) |
0.6 | 2.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.6 | 12.6 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.6 | 5.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.6 | 1.9 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) cellular response to bile acid(GO:1903413) negative regulation of intestinal absorption(GO:1904479) response to iron ion starvation(GO:1990641) |
0.6 | 1.9 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 1.8 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.6 | 11.0 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.6 | 7.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.6 | 4.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 3.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.6 | 4.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 15.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.6 | 5.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 4.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.6 | 13.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 3.0 | GO:0016236 | macroautophagy(GO:0016236) |
0.6 | 4.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.6 | 12.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.6 | 2.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.6 | 10.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.6 | 1.8 | GO:0070781 | response to biotin(GO:0070781) |
0.6 | 2.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.6 | 6.4 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.6 | 8.1 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.6 | 2.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.6 | 2.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.6 | 20.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.6 | 1.7 | GO:0060718 | negative regulation of cytokinesis(GO:0032466) chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 3.4 | GO:1903760 | regulation of potassium ion export(GO:1902302) regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
0.6 | 3.4 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 1.1 | GO:1902623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.6 | 2.2 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.6 | 39.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.6 | 1.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.5 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.5 | 1.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.5 | 2.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.5 | 2.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.5 | 9.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.5 | 1.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 3.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.5 | 1.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.5 | 8.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.5 | 1.6 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.5 | 13.9 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.5 | 2.0 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.5 | 3.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.5 | 11.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.5 | 7.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 1.0 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) regulation of neural retina development(GO:0061074) regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 11.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.5 | 36.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.5 | 10.0 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.5 | 4.4 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.5 | 1.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 25.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.5 | 3.3 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
0.5 | 2.9 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.5 | 17.0 | GO:0014047 | glutamate secretion(GO:0014047) |
0.5 | 2.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
0.5 | 11.8 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 5.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.5 | 3.6 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.4 | 4.0 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.4 | 8.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.4 | 1.3 | GO:0061333 | renal tubule morphogenesis(GO:0061333) nephron epithelium development(GO:0072009) nephron morphogenesis(GO:0072028) |
0.4 | 16.9 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.4 | 1.8 | GO:0043473 | pigmentation(GO:0043473) |
0.4 | 11.4 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.4 | 1.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.4 | 8.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 14.0 | GO:0007094 | mitotic spindle assembly checkpoint(GO:0007094) spindle assembly checkpoint(GO:0071173) |
0.4 | 6.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.4 | 28.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.4 | 6.7 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.4 | 1.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 2.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.4 | 13.5 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.4 | 7.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.4 | 5.7 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.4 | 1.6 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 2.5 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.4 | 2.9 | GO:0042426 | choline catabolic process(GO:0042426) |
0.4 | 4.9 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 5.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 4.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.4 | 5.9 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 1.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 7.6 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
0.4 | 7.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.4 | 2.3 | GO:0043366 | beta selection(GO:0043366) |
0.4 | 1.5 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.4 | 2.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 3.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.4 | 26.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.4 | 3.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 4.0 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 5.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.4 | 17.0 | GO:0048477 | oogenesis(GO:0048477) |
0.4 | 2.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 14.8 | GO:0042073 | intraciliary transport(GO:0042073) |
0.4 | 2.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 3.5 | GO:0099612 | protein localization to axon(GO:0099612) |
0.3 | 8.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.3 | 11.8 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.3 | 6.5 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.3 | 1.4 | GO:0071630 | trophectodermal cellular morphogenesis(GO:0001831) nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.3 | 6.5 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 0.7 | GO:0043132 | NAD transport(GO:0043132) |
0.3 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 3.9 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.3 | 4.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.3 | 7.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 6.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.3 | 5.5 | GO:0032210 | regulation of telomere maintenance via telomerase(GO:0032210) |
0.3 | 0.6 | GO:0060574 | columnar/cuboidal epithelial cell maturation(GO:0002069) intestinal epithelial cell maturation(GO:0060574) |
0.3 | 0.9 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.3 | 1.6 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.3 | 9.0 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.3 | 0.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 5.8 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 4.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 4.0 | GO:0009584 | detection of visible light(GO:0009584) |
0.3 | 6.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.3 | 13.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.3 | 1.2 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 3.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.3 | 1.8 | GO:0051597 | response to methylmercury(GO:0051597) |
0.3 | 1.5 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.3 | 6.9 | GO:0048635 | negative regulation of muscle organ development(GO:0048635) |
0.3 | 0.6 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of sodium:proton antiporter activity(GO:0032417) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of neurotransmitter transport(GO:0051590) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 0.6 | GO:0060324 | face development(GO:0060324) |
0.3 | 11.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 5.0 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.3 | 5.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 14.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.3 | 4.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 3.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.3 | 13.9 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 2.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.3 | 1.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 1.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 3.1 | GO:0048265 | response to pain(GO:0048265) |
0.3 | 1.3 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 10.7 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 2.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.2 | 2.2 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.2 | 3.6 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.2 | 2.4 | GO:0001553 | luteinization(GO:0001553) |
0.2 | 3.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 4.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 9.9 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.2 | 4.8 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.2 | 5.9 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 2.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.2 | 1.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.2 | 3.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 4.5 | GO:0005979 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
0.2 | 3.6 | GO:0001502 | cartilage condensation(GO:0001502) |
0.2 | 5.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 5.3 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 5.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 2.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 8.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 4.3 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.2 | 0.6 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 4.4 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 2.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 0.4 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.2 | 4.1 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.2 | 2.3 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 2.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 10.1 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.2 | 32.4 | GO:0007601 | visual perception(GO:0007601) |
0.2 | 1.3 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 2.0 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 18.3 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.2 | 8.6 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 4.3 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.2 | 0.5 | GO:0019448 | cysteine biosynthetic process from serine(GO:0006535) cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.7 | GO:0045003 | meiotic DNA recombinase assembly(GO:0000707) DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 3.5 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.2 | 3.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 12.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 2.4 | GO:0060384 | innervation(GO:0060384) |
0.2 | 1.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 2.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 1.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 1.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 1.9 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.2 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 2.5 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.2 | 3.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 2.3 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.2 | 0.3 | GO:0035814 | negative regulation of urine volume(GO:0035811) negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 1.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 2.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 1.6 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 1.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 1.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 5.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.4 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0072708 | response to sorbitol(GO:0072708) cellular response to sorbitol(GO:0072709) |
0.1 | 1.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.6 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.9 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.1 | 1.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.5 | GO:0071389 | cellular response to corticosterone stimulus(GO:0071386) cellular response to mineralocorticoid stimulus(GO:0071389) |
0.1 | 2.5 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 1.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 65.7 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 2.0 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 1.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 3.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 3.2 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 4.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.3 | GO:1990173 | establishment of protein localization to telomere(GO:0070200) regulation of establishment of protein localization to telomere(GO:0070203) scaRNA localization to Cajal body(GO:0090666) protein localization to nuclear body(GO:1903405) positive regulation of establishment of protein localization to telomere(GO:1904851) protein localization to Cajal body(GO:1904867) protein localization to nucleoplasm(GO:1990173) |
0.1 | 1.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 2.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 2.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.7 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 1.1 | GO:0032196 | transposition(GO:0032196) |
0.1 | 5.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 1.5 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.1 | 1.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 1.0 | GO:0042552 | myelination(GO:0042552) |
0.1 | 0.5 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 2.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 1.6 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 1.6 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.4 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 1.6 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.6 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.9 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 1.3 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.1 | 0.7 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 0.3 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) cerebral cortex GABAergic interneuron development(GO:0021894) |
0.1 | 1.2 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
0.1 | 0.9 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 10.8 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 1.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 2.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 1.0 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 23.7 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.0 | 0.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.0 | 2.2 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.9 | GO:0030282 | bone mineralization(GO:0030282) |
0.0 | 0.8 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
0.0 | 0.2 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.5 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.7 | GO:0030819 | positive regulation of cAMP biosynthetic process(GO:0030819) |
0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.6 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 1.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.7 | 38.8 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
9.5 | 28.6 | GO:0043198 | dendritic shaft(GO:0043198) |
9.2 | 36.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
8.6 | 42.9 | GO:0071546 | pi-body(GO:0071546) |
8.5 | 67.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
8.3 | 66.7 | GO:0033391 | chromatoid body(GO:0033391) |
7.0 | 7.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
6.3 | 75.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
6.0 | 23.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
4.7 | 23.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
4.2 | 16.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
4.2 | 16.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
4.1 | 24.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
3.9 | 51.2 | GO:0030897 | HOPS complex(GO:0030897) |
3.8 | 11.5 | GO:0019034 | viral replication complex(GO:0019034) |
3.8 | 19.2 | GO:0033263 | CORVET complex(GO:0033263) |
3.7 | 14.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
3.7 | 11.0 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
3.5 | 13.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
3.3 | 10.0 | GO:0044305 | calyx of Held(GO:0044305) |
3.3 | 13.3 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
3.3 | 19.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
3.2 | 16.2 | GO:0089701 | U2AF(GO:0089701) |
3.2 | 22.4 | GO:0044326 | dendritic spine neck(GO:0044326) |
3.1 | 101.0 | GO:0000795 | synaptonemal complex(GO:0000795) |
2.8 | 13.8 | GO:0070847 | core mediator complex(GO:0070847) |
2.7 | 5.4 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
2.6 | 23.6 | GO:0005827 | polar microtubule(GO:0005827) |
2.6 | 43.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.6 | 20.5 | GO:0036157 | outer dynein arm(GO:0036157) |
2.5 | 17.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
2.5 | 41.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.3 | 23.3 | GO:0097433 | dense body(GO:0097433) |
2.3 | 11.6 | GO:0044308 | axonal spine(GO:0044308) |
2.3 | 6.9 | GO:0098536 | deuterosome(GO:0098536) |
2.3 | 11.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.2 | 13.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.1 | 8.5 | GO:0035838 | growing cell tip(GO:0035838) |
2.1 | 14.6 | GO:0072487 | MSL complex(GO:0072487) |
2.0 | 14.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.9 | 5.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.9 | 13.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.9 | 3.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
1.8 | 12.7 | GO:0001520 | outer dense fiber(GO:0001520) |
1.8 | 22.9 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.7 | 5.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
1.7 | 32.5 | GO:0097225 | sperm midpiece(GO:0097225) |
1.7 | 11.8 | GO:1990635 | proximal dendrite(GO:1990635) |
1.7 | 90.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.6 | 7.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.6 | 25.1 | GO:0031045 | dense core granule(GO:0031045) |
1.6 | 1.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.6 | 18.7 | GO:0043203 | axon hillock(GO:0043203) |
1.5 | 4.5 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
1.4 | 9.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.4 | 38.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
1.3 | 7.9 | GO:0032010 | phagolysosome(GO:0032010) |
1.3 | 9.1 | GO:0097452 | GAIT complex(GO:0097452) |
1.3 | 8.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.2 | 30.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.2 | 1.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
1.2 | 5.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.1 | 9.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.1 | 20.0 | GO:0005922 | connexon complex(GO:0005922) |
1.1 | 2.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
1.1 | 19.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.0 | 10.3 | GO:0070938 | contractile ring(GO:0070938) |
1.0 | 5.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.0 | 8.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 10.2 | GO:0000243 | commitment complex(GO:0000243) |
0.9 | 7.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.9 | 4.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.9 | 15.4 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.9 | 8.0 | GO:0032039 | integrator complex(GO:0032039) |
0.9 | 43.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.8 | 3.3 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.8 | 5.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.8 | 14.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.8 | 20.9 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 11.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 37.0 | GO:0016235 | aggresome(GO:0016235) |
0.7 | 41.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 18.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.7 | 3.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.7 | 15.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.7 | 13.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.7 | 5.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.6 | 10.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 3.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.6 | 6.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.6 | 3.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.6 | 4.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.6 | 5.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.6 | 2.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.6 | 13.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 8.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.5 | 4.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 1.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.5 | 15.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.5 | 13.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 8.3 | GO:0043235 | receptor complex(GO:0043235) |
0.5 | 4.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 6.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 12.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.5 | 3.8 | GO:0035976 | AP1 complex(GO:0035976) |
0.5 | 1.9 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 50.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.5 | 3.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.5 | 1.8 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 10.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.4 | 45.7 | GO:0005814 | centriole(GO:0005814) |
0.4 | 2.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 7.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 6.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 12.7 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 12.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 15.5 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.4 | 3.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 13.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.4 | 1.8 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 13.0 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 10.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.3 | 1.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.3 | 5.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 25.0 | GO:0016459 | myosin complex(GO:0016459) |
0.3 | 0.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 9.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 3.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 44.5 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 6.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.3 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 18.7 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.3 | 16.8 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 14.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.3 | 3.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 3.2 | GO:0031082 | BLOC complex(GO:0031082) |
0.3 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 0.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 5.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 14.8 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 1.4 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 4.5 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 7.7 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 10.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 2.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 9.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 1.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 3.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 43.4 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 2.9 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 13.8 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 4.8 | GO:0005929 | cilium(GO:0005929) |
0.2 | 1.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 129.7 | GO:0045202 | synapse(GO:0045202) |
0.2 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 4.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.9 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 0.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 9.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 2.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 4.9 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.2 | 16.5 | GO:0005903 | brush border(GO:0005903) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 1.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 14.8 | GO:0031514 | motile cilium(GO:0031514) |
0.2 | 38.4 | GO:0045121 | membrane raft(GO:0045121) |
0.1 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 16.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 4.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 2.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 4.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 2.3 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.7 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 2.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.1 | 14.5 | GO:0034399 | nuclear periphery(GO:0034399) |
0.1 | 21.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 2.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 1.0 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 3.6 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 2.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 4.9 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 2.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 10.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 4.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 27.0 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 14.6 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 24.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 2.4 | GO:0030424 | axon(GO:0030424) |
0.1 | 2.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 27.8 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 4.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 3.9 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 4.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.9 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 2.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 1.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 65.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.5 | 132.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
15.9 | 63.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
13.1 | 39.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
11.5 | 68.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
10.1 | 30.2 | GO:0004802 | transketolase activity(GO:0004802) |
9.7 | 29.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
9.2 | 36.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
8.8 | 96.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
7.9 | 23.8 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
7.8 | 23.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
7.6 | 167.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
7.5 | 22.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
6.8 | 20.5 | GO:0034584 | piRNA binding(GO:0034584) |
6.8 | 27.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
6.1 | 18.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
6.0 | 48.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
5.7 | 17.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
5.7 | 17.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
5.6 | 16.8 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
5.2 | 15.6 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
4.7 | 19.0 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
4.7 | 14.1 | GO:0019961 | interferon binding(GO:0019961) |
4.6 | 23.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
4.4 | 39.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
4.3 | 25.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
4.2 | 16.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
4.1 | 24.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
4.0 | 12.0 | GO:0004103 | choline kinase activity(GO:0004103) |
3.8 | 11.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
3.8 | 11.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
3.8 | 11.4 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
3.7 | 58.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
3.7 | 11.0 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
3.6 | 7.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
3.5 | 10.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
3.5 | 17.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
3.5 | 27.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
3.4 | 20.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
3.4 | 20.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
3.4 | 10.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
3.3 | 9.8 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
3.2 | 16.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
3.2 | 9.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
3.2 | 9.6 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
3.2 | 28.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
3.1 | 24.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
3.1 | 30.8 | GO:0009374 | biotin binding(GO:0009374) |
3.1 | 12.3 | GO:0035939 | microsatellite binding(GO:0035939) |
2.9 | 11.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.9 | 8.8 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
2.9 | 31.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.8 | 13.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.7 | 8.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
2.7 | 8.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
2.7 | 13.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
2.7 | 8.0 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
2.7 | 26.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.7 | 8.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
2.7 | 10.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
2.7 | 10.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
2.6 | 12.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
2.5 | 4.9 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
2.5 | 4.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
2.5 | 9.8 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
2.4 | 7.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
2.4 | 40.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.3 | 30.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.3 | 13.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.3 | 32.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
2.2 | 60.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
2.1 | 10.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.1 | 27.3 | GO:0031005 | filamin binding(GO:0031005) |
2.0 | 8.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
2.0 | 4.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
2.0 | 3.9 | GO:0070888 | E-box binding(GO:0070888) |
2.0 | 19.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.9 | 9.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.9 | 9.6 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.9 | 5.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.9 | 5.6 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
1.8 | 29.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.8 | 29.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.8 | 9.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.8 | 25.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.8 | 7.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.8 | 7.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.7 | 7.0 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) aspartic-type endopeptidase inhibitor activity(GO:0019828) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.7 | 3.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.7 | 24.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
1.7 | 5.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.7 | 24.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.7 | 5.0 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
1.7 | 8.4 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.7 | 6.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.7 | 18.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.7 | 8.4 | GO:0052844 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
1.6 | 16.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.6 | 4.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.6 | 64.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.5 | 15.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
1.5 | 18.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.5 | 3.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
1.5 | 4.5 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
1.5 | 7.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.5 | 4.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.5 | 17.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
1.5 | 25.1 | GO:0015250 | water channel activity(GO:0015250) |
1.4 | 8.6 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
1.4 | 4.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.4 | 6.9 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
1.4 | 11.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.4 | 39.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.3 | 30.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.3 | 8.0 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
1.3 | 18.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.3 | 8.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.2 | 13.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.2 | 37.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 4.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.2 | 34.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
1.2 | 9.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.2 | 4.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.1 | 5.7 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
1.1 | 28.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.1 | 3.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.1 | 40.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
1.1 | 4.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 2.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.1 | 2.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
1.1 | 20.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.1 | 3.2 | GO:0070538 | oleic acid binding(GO:0070538) |
1.1 | 12.7 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
1.0 | 10.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.0 | 20.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.0 | 11.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 5.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.0 | 4.0 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
1.0 | 5.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
1.0 | 8.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.0 | 2.9 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
1.0 | 3.8 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.0 | 4.8 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
1.0 | 2.9 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.9 | 10.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.9 | 5.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.9 | 31.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.9 | 33.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.9 | 3.7 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.9 | 13.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.9 | 48.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.9 | 11.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.9 | 15.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.9 | 3.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.9 | 17.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.9 | 14.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.8 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 2.5 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.8 | 10.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.8 | 55.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.8 | 29.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.8 | 79.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.8 | 15.9 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.7 | 13.5 | GO:0005522 | profilin binding(GO:0005522) |
0.7 | 2.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.7 | 3.0 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
0.7 | 8.9 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.7 | 1.5 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.7 | 5.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.7 | 2.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 1.4 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.7 | 9.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.7 | 15.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.7 | 11.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.7 | 11.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.7 | 2.7 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.7 | 2.7 | GO:0043559 | insulin binding(GO:0043559) |
0.6 | 2.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.6 | 8.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.6 | 12.1 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.6 | 0.6 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.6 | 2.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.6 | 3.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 1.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.6 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.6 | 1.8 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.6 | 3.0 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.6 | 7.7 | GO:0031432 | titin binding(GO:0031432) |
0.6 | 3.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.6 | 5.9 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 2.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.6 | 18.8 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.6 | 6.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 7.6 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.6 | 21.9 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.6 | 3.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.6 | 4.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 2.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.5 | 2.2 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 1.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 9.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.5 | 1.6 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.5 | 3.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.5 | 11.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 15.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.5 | 4.2 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.5 | 23.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.5 | 14.0 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 12.3 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 32.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.5 | 12.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 5.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.5 | 4.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.5 | 11.6 | GO:0005521 | lamin binding(GO:0005521) |
0.5 | 10.0 | GO:0032451 | demethylase activity(GO:0032451) |
0.5 | 3.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.5 | 7.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 1.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.5 | 11.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.5 | 4.5 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.5 | 3.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 11.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.4 | 5.3 | GO:0019864 | IgG binding(GO:0019864) |
0.4 | 19.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.4 | 18.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 6.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.4 | 2.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.4 | 28.7 | GO:0019905 | syntaxin binding(GO:0019905) |
0.4 | 1.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.4 | 14.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 100.7 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.4 | 4.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 2.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.4 | 4.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 8.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.4 | 23.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.4 | 2.4 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 1.6 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 3.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 1.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.4 | 2.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.4 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 4.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 141.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.3 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 2.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 3.7 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.3 | 7.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.3 | 1.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 3.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.3 | 8.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.9 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.3 | 8.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 3.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.3 | 2.2 | GO:0034452 | dynactin binding(GO:0034452) |
0.3 | 3.4 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 2.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 3.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 3.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 13.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 6.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.3 | 5.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.3 | 11.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 7.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.3 | 18.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.3 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.3 | 2.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.3 | 4.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.3 | 9.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 4.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 33.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 3.0 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.2 | 4.7 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.2 | 2.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 1.9 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 5.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 36.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 25.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 13.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.2 | 71.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 21.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 42.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 8.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.2 | 4.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 8.4 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 1.0 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 8.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 4.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 5.0 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 2.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 4.4 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.2 | 0.5 | GO:1904047 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) S-adenosyl-L-methionine binding(GO:1904047) |
0.2 | 3.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 4.6 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.2 | 3.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 18.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 1.8 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 8.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 2.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 2.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.2 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 5.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 5.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 16.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 39.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 1.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 2.0 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 2.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 4.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 2.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 1.2 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.1 | 0.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 2.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 7.9 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 8.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.4 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.6 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.1 | 2.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 3.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 5.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 3.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 1.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 1.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.3 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 2.0 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.3 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.2 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 1.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 56.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.3 | 44.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.2 | 8.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.2 | 30.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.1 | 61.9 | PID AURORA A PATHWAY | Aurora A signaling |
1.1 | 50.3 | PID REELIN PATHWAY | Reelin signaling pathway |
1.0 | 24.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.0 | 14.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.9 | 14.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.9 | 19.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.9 | 24.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 16.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.9 | 12.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.8 | 7.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.7 | 7.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.7 | 9.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.7 | 19.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.6 | 11.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 25.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 25.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.6 | 11.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.5 | 13.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.5 | 8.6 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 11.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 19.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 10.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 8.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.5 | 12.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 3.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.4 | 23.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 8.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 3.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 4.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 33.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.3 | 3.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 14.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 8.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 17.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 3.2 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 34.8 | PID P73PATHWAY | p73 transcription factor network |
0.3 | 17.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 6.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 4.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 12.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 3.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 12.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 3.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 11.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 2.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 11.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 11.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 3.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 7.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 5.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 3.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 14.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 8.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 4.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 4.5 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 5.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 2.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 4.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 3.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 2.8 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 2.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 2.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.1 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 11.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 3.2 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 101.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.4 | 4.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
2.0 | 76.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.9 | 28.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.8 | 43.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.8 | 25.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 24.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.6 | 73.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.6 | 44.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 18.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.5 | 32.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.5 | 32.0 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
1.4 | 29.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 31.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.3 | 25.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.3 | 66.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.3 | 13.9 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.2 | 10.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.2 | 17.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.1 | 21.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.1 | 20.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
1.1 | 74.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.0 | 51.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 14.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.9 | 6.4 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.9 | 2.7 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.9 | 23.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.9 | 13.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.8 | 74.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.8 | 9.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.8 | 13.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.7 | 24.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.7 | 16.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.7 | 11.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.7 | 8.3 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.7 | 5.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 12.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.7 | 10.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.7 | 19.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 14.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 12.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.6 | 12.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 46.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 5.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.6 | 11.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 11.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.6 | 14.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 7.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.5 | 6.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 6.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 11.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 44.9 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.5 | 8.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 26.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.5 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.5 | 11.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 13.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 105.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 14.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.4 | 4.9 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.4 | 9.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.4 | 4.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 6.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.4 | 13.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 36.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.4 | 4.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.4 | 8.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.4 | 18.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.4 | 3.0 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 8.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.4 | 7.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 11.5 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 3.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 8.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 2.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.3 | 7.2 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.3 | 13.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.3 | 9.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 11.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.3 | 2.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 1.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 16.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 4.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.3 | 6.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 26.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 11.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.3 | 11.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 2.2 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 3.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.3 | 4.7 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.3 | 12.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 5.3 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.2 | 4.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.2 | 3.1 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 1.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 17.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 3.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 10.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 3.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 3.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 2.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 4.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.5 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 0.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 12.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 1.0 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.7 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |